Literature DB >> 24576999

Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.

Carla J Walraven1,2, Stella M Bernardo1,2, Nathan P Wiederhold3,4, Samuel A Lee1,2.   

Abstract

Echinocandin-resistant clinical isolates of Candida albicans have been reported, and key-hot spot mutations in the FKS1 gene, which encodes a major glucan synthase subunit, have been identified in these (caspofungin-resistant [CAS-R]) strains. Although these mutations result in phenotypic resistance to echinocandins in planktonic cells, there is little data on antifungal susceptibilities of CAS-R C. albicans strains within biofilms. Thus, we analyzed biofilms formed by 12 C. albicans CAS-R clinical strains in which we previously identified FKS1 hot-spot mutations and compared the sessile antifungal and paradoxical activity of anidulafungin (ANID), caspofungin (CAS), and micafungin (MICA). Biofilms were formed in a 96-well static microplate model and assayed using both tetrazolium-salt reduction and crystal violet assays, as well as examination by scanning electron microscopy. We first sought to assess biofilm formation and structure in these fks1 mutants and found that the biofilm mass and metabolic activities were reduced in most of the fks1 mutants as compared with reference strain SC5314. Structural analyses revealed that the fks1 mutant biofilms were generally less dense and had a clear predominance of yeast and pseudohyphae, with unusual "pit"-like cell surface structures. We also noted that sessile minimum inhibitory concentrations (MICs) to ANID, CAS, and MICA were higher than planktonic MICs of all but one strain. The majority of strains demonstrated a paradoxical effect (PE) to particular echinocandins, in either planktonic or sessile forms. Overall, biofilms formed by echinocandin-resistant clinical isolates demonstrated varied PEs to echinocandins and were structurally characterized by a preponderance of yeast, pseudohyphae, and pit-like structures.

Entities:  

Keywords:  Candida albicans; antifungal therapy; biofilms

Mesh:

Substances:

Year:  2013        PMID: 24576999      PMCID: PMC5189660          DOI: 10.1093/mmy/myt007

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  39 in total

1.  Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.

Authors:  Nathan P Wiederhold; Jodi L Grabinski; Guillermo Garcia-Effron; David S Perlin; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2008-09-15       Impact factor: 5.191

2.  In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms.

Authors:  Marisa H Miceli; Stella M Bernardo; Samuel A Lee
Journal:  Int J Antimicrob Agents       Date:  2009-08-11       Impact factor: 5.283

3.  Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum.

Authors:  Ryan K Shields; M Hong Nguyen; Chen Du; Ellen Press; Shaoji Cheng; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

4.  Studies of the paradoxical effect of caspofungin at high drug concentrations.

Authors:  David A Stevens; Theodore C White; David S Perlin; Claude P Selitrennikoff
Journal:  Diagn Microbiol Infect Dis       Date:  2005-03       Impact factor: 2.803

5.  Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.

Authors:  Varsha Moudgal; Tania Little; Dina Boikov; Jose A Vazquez
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.

Authors:  Christopher D Miller; Ben W Lomaestro; Steven Park; David S Perlin
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

Review 7.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Anidulafungin versus fluconazole for invasive candidiasis.

Authors:  Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; Thomas J Walsh
Journal:  N Engl J Med       Date:  2007-06-14       Impact factor: 91.245

9.  A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.

Authors:  Alvaro Villanueva; Eduardo Gotuzzo; Eduardo G Arathoon; L Miguel Noriega; Nicholas A Kartsonis; Robert J Lupinacci; Juanita M Smietana; Mark J DiNubile; Carole A Sable
Journal:  Am J Med       Date:  2002-09       Impact factor: 4.965

10.  Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates.

Authors:  J A G Ferreira; J H Carr; C E F Starling; M A de Resende; R M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

View more
  7 in total

1.  In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation.

Authors:  Alba A Chavez-Dozal; Livia Lown; Maximillian Jahng; Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

2.  Garcinia xanthochymus Benzophenones Promote Hyphal Apoptosis and Potentiate Activity of Fluconazole against Candida albicans Biofilms.

Authors:  Desmond N Jackson; Lin Yang; ShiBiao Wu; Edward J Kennelly; Peter N Lipke
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

3.  Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.

Authors:  Laura Judith Marcos-Zambrano; Marta Gómez-Perosanz; Pilar Escribano; Oscar Zaragoza; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.

Authors:  Małgorzata Prażyńska; Tomasz Bogiel; Eugenia Gospodarek-Komkowska
Journal:  Folia Microbiol (Praha)       Date:  2017-10-05       Impact factor: 2.099

5.  Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.

Authors:  Francisco Madariaga-Venegas; Roberto Fernández-Soto; Luisa Fernanda Duarte; Nicole Suarez; Daniela Delgadillo; José A Jara; Ricardo Fernández-Ramires; Blanca Urzúa; Alfredo Molina-Berríos
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

Review 6.  Recent Insights into the Paradoxical Effect of Echinocandins.

Authors:  Johannes Wagener; Veronika Loiko
Journal:  J Fungi (Basel)       Date:  2017-12-28

7.  Activity of Free and Liposome-Encapsulated Essential Oil from Lavandula angustifolia against Persister-Derived Biofilm of Candida auris.

Authors:  Elisabetta de Alteriis; Angela Maione; Annarita Falanga; Rosa Bellavita; Stefania Galdiero; Luisa Albarano; Maria Michela Salvatore; Emilia Galdiero; Marco Guida
Journal:  Antibiotics (Basel)       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.